V. Ibarra-Bracamontes

Anti-11[E]-pyroglutamate-modified amyloid β antibodies cross-react with other pathological Aβ species: Relevance for immunotherapy

T. Govezensky, V. Vasilevko, D. Cribbs, 2010, Journal of Neuroimmunology.

Phospho-Tau Protein Expression in the Cell Cycle of SH-SY5Y Neuroblastoma Cells: A Morphological Study.

C. Harrington, A. Alonso, C. Wischik, 2019, Journal of Alzheimer's disease : JAD.

Accumulation of Abnormally Processed Tau Protein in Neuronal Cells as a Biomarker for Dementia

I. Ferrer, J. Luna-Muñoz, R. Mena, 2014 .

Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer’s disease brains

D. Řípová, F. García-Sierra, Z. Krištofíková, 2020, Brain Research.